- TitleCEO, GSK Consumer Healthcare
Walmsley runs GSK’s $10 billion consumer healthcare unit, a portfolio of popular OTC brands including Horlicks, Sensodyne and Flonase that now accounts for 26% of the drugmaker’s 2015 sales. The division, formed in 2014 as a joint venture between Novartis and GSK, operates in 160 countries. In 2015, Walmsley continued to lead the integration of the business while getting good results: global sales for the group increased 44%; profits jumped 76%.
|Market Value (as of 8/26/16)|